| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
10x Fund, L.P. is 10% Owner at GALT.
Historically, 10x Fund, L.P.'s trades have earned a strong insider score of 85/100 across 21 rated trades. Over a 12-month horizon, all 17 of those trades were profitable, with an average 12-month return of +47.1%.
The GALT filings lean toward selling, a net 1,293,937 shares.
10x Fund, L.P. has 37 Form 4 filings on record from April 2016 to December 2025, all as 10% Owner at Galectin Therapeutics (GALT), 2016–2025.
The 72 reported transactions were 44 open-market sales, 12 other transactions, 12 open-market purchases and 4 conversions.
Counted by filing, the open-market trades come to no purchases and 29 sales worth about $7.3M.
The largest open-market sale was 208,140 shares of GALT at an average $7.17 on June 13, 2018, about $1.5M.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 30,681 | $6.66 | $204,335.46 | -0.5% | -48.7% | - | |
| Dec 3, 2025 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 150,000 | $5.68 | $851,700.00 | -2.6% | -47.7% | - | |
| Nov 11, 2025 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 40,000 | $5.25 | $210,000.00 | -0.7% | -50.5% | - | |
| Oct 22, 2025 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 50,000 | $4.94 | $246,800.00 | -0.8% | -38.7% | -30.7% | |
| Jul 22, 2022 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 10,000 | $2.09 | $20,870.00 | -0.2% | -15.1% | -11.9% | |
| Feb 2, 2022 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 10,000 | $2.10 | $21,000.00 | -0.2% | -27.2% | -44.7% | |
| Jan 11, 2022 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 10,000 | $2.10 | $21,000.00 | -0.2% | -27.9% | -46.1% | |
| Dec 2, 2021 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 10,000 | $2.37 | $23,700.00 | -0.2% | -25.3% | -50.2% | |
| Nov 1, 2021 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 10,000 | $3.19 | $31,900.00 | -0.2% | -41.0% | -57.5% | |
| Oct 15, 2021 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 10,000 | $3.37 | $33,700.00 | -0.2% | -39.8% | -51.9% |